Stay updated on Idasanutlin Combo in AML: Clinical Trial

Sign up to get notified when there's something new on the Idasanutlin Combo in AML: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Idasanutlin Combo in AML: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the study record continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:14:26.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A sitewide NIH alert announces transition updates and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).
    Difference
    1%
    Check dated 2026-10-24T13:03:57.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.1 to v3.7.2, while the study page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T13:17:02.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T14:06:33.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error for the study record, replacing detailed study content with a minimal error header and a Home link, and a site revision tag appears as part of the new page state.
    Difference
    19%
    Check dated 2026-09-19T18:37:00.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page now includes a 2014 NIH grant/contract attribution and shows the revision updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T19:13:38.000Z thumbnail image

Stay in the know with updates to Idasanutlin Combo in AML: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo in AML: Clinical Trial page.